P53 pathway and cancer: From bench to clinic

Publication date: Available online 2 May 2015 Source:Personalized Medicine Universe Author(s): Takashi Tokino , Masashi Idogawa , Yasushi Sasaki Next-generation sequencing has revealed the genomic landscapes of human cancers and has strengthened the claim that TP53 is the most frequently mutated gene in human cancers. In this review, we intend to clarify the molecular mechanisms underlying the tumor suppressive functions of p53 and understand the involvement of the p53 signaling pathway in tumorigenesis. One of the major goals of this review is to guide the development of more effective approaches for reducing cancer prevalence and fatality.
Source: Personalized Medicine Universe - Category: Drugs & Pharmacology Source Type: research